DOD Biotech Public Company Limited / Fundamentals
Income statement
- Net revenue
€16.91M - Cost of goods sold
€11.00M - Gross profit
€5.91M - SG&A expenses
€4.91M - R&D expenses
€0.00 - EBITDA
€2.57M - D&A
€1.18M - EBIT
€1.35M - Interest expenses
€69.79K - EBT
€1.32M - Tax expenses
€232.76K - Net income
€1.27M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.36M - Changes in working capital
€747.86K - Operating cash flow
€1.86M - Capex
€1.39M - Other investing cash flow
€6.66M - Net investing cash flow
€2.23M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€845.42K - Other financing cash flow
-€0.13 - Net financing cash flow
-€845.42K - Foreign exchange effects
€0.00 - Net change in cash
€3.25M - Cash at end of period
€5.23M - Free cash flow
€3.25M
Balance sheet
- Cash and cash equivalents
€5.23M - Cash and short-term investments
€6.83M - Total receivables
€1.56M - Inventory
€2.73M - Other current assets
€909.86K - Total current assets
€12.03M - Property, plant & equipment
€13.38M - Goodwill
€6.61K - Intangible assets
€1.05M - Long-term investments
€68.23K - Other non-current assets
€460.32K - Total non-current assets
€17.15M - Total assets
€29.18M - Accounts payable
€1.98M - Short-term debt
€461.84K - Other current liabilities
€34.72K - Total current liabilities
€3.03M - Long-term debt
€1.04M - Deferred tax liabilities
€318.03K - Other non-current liabilities
€366.98K - Total non-current liabilities
€1.72M - Total liabilities
€4.75M - Common stock
€5.91M - Retained earnings
€1.29M - Other equity
€251.93K - Total equity
€24.43M - Total liabilities and shareholders' equity
€29.18M
Company information
- Market capitalization
€18.07M - Employees
0 - Enterprise Value
€686.86M
Company ratios
- Gross margin
-
34.9% Better than peer group: 29.8% - EBITDA margin
-
15.2% Even with peer group: 16.9% - EBIT margin
-
8.0% Even with peer group: 12.9% - EBT margin
-
7.8% Even with peer group: 12.4% - Net margin
-
7.5% Even with peer group: 10.3% - ROE
-
5.2% Worse than peer group: 17.7% - ROA
-
4.4% Worse than peer group: 9.4% - Asset turnover
-
57.9% Much worse than peer group: 100.8% - FCF margin
-
2.8% Even with peer group: 3.7% - FCF yield
2.6% - Efficiency ratio
84.8% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00